Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01045928
Recruitment Status : Terminated (Extreme toxicity in Phase I, study did not proceed to Phase II)
First Posted : January 11, 2010
Last Update Posted : November 26, 2015
Information provided by (Responsible Party):
Case Comprehensive Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2011
  Actual Study Completion Date : March 2012